Germany
· Delayed Price · Currency is EUR Bio-Gate AG Statistics
Total Valuation
Bio-Gate AG has a market cap or net worth of EUR 8.46 million. The enterprise value is 8.63 million.
| Market Cap | 8.46M |
| Enterprise Value | 8.63M |
Important Dates
The next estimated earnings date is Tuesday, September 2, 2025.
| Earnings Date | Sep 2, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Bio-Gate AG has 9.24 million shares outstanding. The number of shares has increased by 5.56% in one year.
| Current Share Class | 9.24M |
| Shares Outstanding | 9.24M |
| Shares Change (YoY) | +5.56% |
| Shares Change (QoQ) | -5.07% |
| Owned by Insiders (%) | 8.91% |
| Owned by Institutions (%) | 11.64% |
| Float | 4.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.19 |
| PB Ratio | 4.73 |
| P/TBV Ratio | 11.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.32 |
| EV / Sales | 1.22 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.82 |
Financial Position
The company has a current ratio of 1.09, with a Debt / Equity ratio of 0.24.
| Current Ratio | 1.09 |
| Quick Ratio | 0.25 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.34 |
| Interest Coverage | -28.75 |
Financial Efficiency
Return on equity (ROE) is -63.53% and return on invested capital (ROIC) is -32.96%.
| Return on Equity (ROE) | -63.53% |
| Return on Assets (ROA) | -21.79% |
| Return on Invested Capital (ROIC) | -32.96% |
| Return on Capital Employed (ROCE) | -82.99% |
| Revenue Per Employee | 157,559 |
| Profits Per Employee | -36,038 |
| Employee Count | 45 |
| Asset Turnover | 1.54 |
| Inventory Turnover | 2.04 |
Taxes
In the past 12 months, Bio-Gate AG has paid 96 in taxes.
| Income Tax | 96 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.09% in the last 52 weeks. The beta is 0.32, so Bio-Gate AG's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | -6.09% |
| 50-Day Moving Average | 0.99 |
| 200-Day Moving Average | 0.82 |
| Relative Strength Index (RSI) | 48.33 |
| Average Volume (20 Days) | 4,018 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bio-Gate AG had revenue of EUR 7.09 million and -1.62 million in losses. Loss per share was -0.18.
| Revenue | 7.09M |
| Gross Profit | 4.14M |
| Operating Income | -1.60M |
| Pretax Income | -1.66M |
| Net Income | -1.62M |
| EBITDA | -1.30M |
| EBIT | -1.60M |
| Loss Per Share | -0.18 |
Balance Sheet
The company has 296,624 in cash and 429,000 in debt, giving a net cash position of -132,376 or -0.01 per share.
| Cash & Cash Equivalents | 296,624 |
| Total Debt | 429,000 |
| Net Cash | -132,376 |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 1.79M |
| Book Value Per Share | 0.19 |
| Working Capital | 179,595 |
Cash Flow
In the last 12 months, operating cash flow was -1.22 million and capital expenditures -49,000, giving a free cash flow of -1.27 million.
| Operating Cash Flow | -1.22M |
| Capital Expenditures | -49,000 |
| Free Cash Flow | -1.27M |
| FCF Per Share | -0.14 |
Margins
Gross margin is 58.32%, with operating and profit margins of -22.63% and -22.87%.
| Gross Margin | 58.32% |
| Operating Margin | -22.63% |
| Pretax Margin | -23.47% |
| Profit Margin | -22.87% |
| EBITDA Margin | -18.34% |
| EBIT Margin | -22.63% |
| FCF Margin | n/a |
Dividends & Yields
Bio-Gate AG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.56% |
| Shareholder Yield | n/a |
| Earnings Yield | -19.17% |
| FCF Yield | -14.97% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 26, 2012. It was a reverse split with a ratio of 0.25.
| Last Split Date | Nov 26, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.25 |
Scores
Bio-Gate AG has an Altman Z-Score of -1.96 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.96 |
| Piotroski F-Score | 3 |